Company news

Creative Medical Technology Holdings, Inc. news in 2020

Creative Medical Technology Holdings, Inc.'s news releases, calls and decks from 2020, newest first.

View company

Creative Medical Technology Holdings Announces Patent filing based on Preclinical Data in Model of Heart Attack using ImmCelz® Regenerative Immunotherapy

December 30, 2020

Creative Medical Technology Holdings Announces Reversion of Liver Failure Using ImmCelz® Personalized Cellular Immunotherapy in Preclinical Model

December 28, 2020

Creative Medical Technology Holdings Identifies Mechanism of Action of ImmCelz® Stroke Regenerative Activity

December 21, 2020

Creative Medical Technology Holdings Announces Successful Application of ImmCelz® Immunotherapy for Treatment of Stroke

December 15, 2020

Creative Medical Technology Holdings files Patent on Induction of Infectious Tolerance by Ex Vivo Reprogrammed Immune Cells Utilizing ImmCelz® Cellular Immunotherapy

December 9, 2020

Creative Medical Technology Holdings Reports Positive Preclinical Data on ImmCelz® Immunotherapy Product in Rheumatoid Arthritis Model

September 28, 2020

Creative Medical Technology Holdings, Inc. September 2020 Shareholder Update

September 23, 2020

Creative Medical Technology Holdings Identifies Novel Mechanism of Action of AmnioStem™ Adult Stem Cell Product in Stroke

August 19, 2020

Creative Medical Technology Holdings Completes AmnioStem™ Preclinical Studies Needed for FDA Investigational New Drug Application Filing

July 8, 2020

Creative Medical Technology Holdings is Granted Patent on Mesenchymal Stem Cells for Female Infertility Pending Quayle Action

April 19, 2020

Creative Medical Technology Holdings Announces IMMCELZ™ Adoptive Immunotherapy Product

March 10, 2020